MORGAN STANLEY PLC/PUT/PFIZER INC/30/0.1/20.12.24 Stock

Warrant

DE000MB4AMH4

Real-time Bid/Ask 09:40:47 2024-07-17 am EDT
0.201 EUR / 0.203 EUR -8.60% Intraday chart for MORGAN STANLEY PLC/PUT/PFIZER INC/30/0.1/20.12.24
Current month-26.33%
1 month-33.03%
Date Price Change
24-07-17 0.223 +0.90%
24-07-16 0.221 -4.33%
24-07-15 0.231 -3.75%
24-07-12 0.24 -11.11%
24-07-11 0.27 -6.90%

Delayed Quote Börse Stuttgart

Last update July 17, 2024 at 04:53 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB4AMH
ISINDE000MB4AMH4
Date issued 2023-03-13
Strike 30 $
Maturity 2024-12-20 (156 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.53
Lowest since issue 0.106
Spread 0.002
Spread %0.94%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
29.5 USD
Average target price
32.1 USD
Spread / Average Target
+8.80%
Consensus